

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of posttranscriptional gene silencing (GO:0060147) | 6.22179783 |
| 2 | regulation of gene silencing by miRNA (GO:0060964) | 6.22179783 |
| 3 | regulation of gene silencing by RNA (GO:0060966) | 6.22179783 |
| 4 | pre-miRNA processing (GO:0031054) | 5.34765272 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.30385626 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 5.30385626 |
| 7 | regulation of histone H3-K9 methylation (GO:0051570) | 5.29749115 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.14834389 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 5.14834389 |
| 10 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 4.85839399 |
| 11 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 4.85839399 |
| 12 | regulation of translation, ncRNA-mediated (GO:0045974) | 4.85839399 |
| 13 | lysine metabolic process (GO:0006553) | 4.68773091 |
| 14 | lysine catabolic process (GO:0006554) | 4.68773091 |
| 15 | histone H3-K36 demethylation (GO:0070544) | 4.50786183 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 4.46488296 |
| 17 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.39362440 |
| 18 | aromatic amino acid family catabolic process (GO:0009074) | 4.38715931 |
| 19 | cysteine metabolic process (GO:0006534) | 4.35308851 |
| 20 | mitotic sister chromatid cohesion (GO:0007064) | 4.32583225 |
| 21 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.25979903 |
| 22 | urea cycle (GO:0000050) | 4.15679749 |
| 23 | urea metabolic process (GO:0019627) | 4.15679749 |
| 24 | kynurenine metabolic process (GO:0070189) | 4.15484314 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 4.08535784 |
| 26 | regulation of meiosis I (GO:0060631) | 4.04533644 |
| 27 | glutamate metabolic process (GO:0006536) | 4.03987495 |
| 28 | negative regulation of histone methylation (GO:0031061) | 4.00375316 |
| 29 | regulation of cholesterol homeostasis (GO:2000188) | 3.98140957 |
| 30 | synapsis (GO:0007129) | 3.97968954 |
| 31 | regulation of DNA methylation (GO:0044030) | 3.96863826 |
| 32 | bile acid biosynthetic process (GO:0006699) | 3.92283451 |
| 33 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.91284956 |
| 34 | glyoxylate metabolic process (GO:0046487) | 3.88055534 |
| 35 | regulation of chromatin silencing (GO:0031935) | 3.87170818 |
| 36 | cellular ketone body metabolic process (GO:0046950) | 3.86883544 |
| 37 | aspartate family amino acid catabolic process (GO:0009068) | 3.86842825 |
| 38 | serine family amino acid catabolic process (GO:0009071) | 3.86768901 |
| 39 | paraxial mesoderm development (GO:0048339) | 3.77499879 |
| 40 | 2-oxoglutarate metabolic process (GO:0006103) | 3.76638954 |
| 41 | nitrogen cycle metabolic process (GO:0071941) | 3.74052133 |
| 42 | regulation of gene silencing (GO:0060968) | 3.70856334 |
| 43 | fatty acid transmembrane transport (GO:1902001) | 3.69826770 |
| 44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.68976429 |
| 45 | negative regulation of fibroblast apoptotic process (GO:2000270) | 3.68658081 |
| 46 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.65084813 |
| 47 | carnitine shuttle (GO:0006853) | 3.63778055 |
| 48 | indolalkylamine catabolic process (GO:0046218) | 3.60591661 |
| 49 | tryptophan catabolic process (GO:0006569) | 3.60591661 |
| 50 | indole-containing compound catabolic process (GO:0042436) | 3.60591661 |
| 51 | homocysteine metabolic process (GO:0050667) | 3.58841889 |
| 52 | negative regulation of fibrinolysis (GO:0051918) | 3.57407099 |
| 53 | bile acid metabolic process (GO:0008206) | 3.56907610 |
| 54 | high-density lipoprotein particle remodeling (GO:0034375) | 3.56771036 |
| 55 | triglyceride homeostasis (GO:0070328) | 3.56367866 |
| 56 | acylglycerol homeostasis (GO:0055090) | 3.56367866 |
| 57 | histone H3-K9 demethylation (GO:0033169) | 3.55905136 |
| 58 | regulation of triglyceride catabolic process (GO:0010896) | 3.55602269 |
| 59 | amino-acid betaine metabolic process (GO:0006577) | 3.53164302 |
| 60 | alpha-amino acid catabolic process (GO:1901606) | 3.49691334 |
| 61 | acetyl-CoA metabolic process (GO:0006084) | 3.47173412 |
| 62 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.44652572 |
| 63 | tryptophan metabolic process (GO:0006568) | 3.42075610 |
| 64 | complement activation, alternative pathway (GO:0006957) | 3.39252756 |
| 65 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.38837223 |
| 66 | short-chain fatty acid metabolic process (GO:0046459) | 3.37578218 |
| 67 | regulation of fibrinolysis (GO:0051917) | 3.37271273 |
| 68 | nuclear pore complex assembly (GO:0051292) | 3.36680416 |
| 69 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.36410546 |
| 70 | cellular amino acid catabolic process (GO:0009063) | 3.32107072 |
| 71 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.31325885 |
| 72 | negative regulation of inclusion body assembly (GO:0090084) | 3.30914516 |
| 73 | regulation of protein activation cascade (GO:2000257) | 3.30717375 |
| 74 | protein complex localization (GO:0031503) | 3.29114519 |
| 75 | nerve growth factor signaling pathway (GO:0038180) | 3.28627241 |
| 76 | negative regulation of gene silencing (GO:0060969) | 3.28418676 |
| 77 | ketone body metabolic process (GO:1902224) | 3.28198314 |
| 78 | protein carboxylation (GO:0018214) | 3.27754243 |
| 79 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.27754243 |
| 80 | sister chromatid cohesion (GO:0007062) | 3.27443348 |
| 81 | cellular modified amino acid catabolic process (GO:0042219) | 3.25021383 |
| 82 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.25016666 |
| 83 | drug catabolic process (GO:0042737) | 3.24006405 |
| 84 | fatty acid beta-oxidation (GO:0006635) | 3.21515065 |
| 85 | positive regulation of lipid catabolic process (GO:0050996) | 3.18862113 |
| 86 | regulation of bile acid biosynthetic process (GO:0070857) | 3.17673808 |
| 87 | reverse cholesterol transport (GO:0043691) | 3.15520116 |
| 88 | fatty acid homeostasis (GO:0055089) | 3.15476862 |
| 89 | cellular protein complex localization (GO:0034629) | 3.14430070 |
| 90 | fatty acid oxidation (GO:0019395) | 3.13237688 |
| 91 | DNA synthesis involved in DNA repair (GO:0000731) | 3.13146414 |
| 92 | RNA stabilization (GO:0043489) | 3.12808159 |
| 93 | mRNA stabilization (GO:0048255) | 3.12808159 |
| 94 | aromatic amino acid family metabolic process (GO:0009072) | 3.12779405 |
| 95 | nuclear pore organization (GO:0006999) | 3.12666840 |
| 96 | positive regulation of catenin import into nucleus (GO:0035413) | 3.12367477 |
| 97 | plasma lipoprotein particle clearance (GO:0034381) | 3.10511773 |
| 98 | tyrosine metabolic process (GO:0006570) | 3.08195022 |
| 99 | dicarboxylic acid catabolic process (GO:0043649) | 3.07703276 |
| 100 | regulation of complement activation (GO:0030449) | 3.07532511 |
| 101 | lipid oxidation (GO:0034440) | 3.07408393 |
| 102 | negative regulation of sterol transport (GO:0032372) | 3.05538747 |
| 103 | negative regulation of cholesterol transport (GO:0032375) | 3.05538747 |
| 104 | regulation of mRNA stability (GO:0043488) | 3.05412463 |
| 105 | interkinetic nuclear migration (GO:0022027) | 3.03671928 |
| 106 | ethanol oxidation (GO:0006069) | 3.03079988 |
| 107 | macroautophagy (GO:0016236) | 3.01616863 |
| 108 | plasma lipoprotein particle remodeling (GO:0034369) | 3.01161407 |
| 109 | protein-lipid complex remodeling (GO:0034368) | 3.01161407 |
| 110 | macromolecular complex remodeling (GO:0034367) | 3.01161407 |
| 111 | ncRNA catabolic process (GO:0034661) | 3.00334991 |
| 112 | histone lysine demethylation (GO:0070076) | 2.99796852 |
| 113 | carnitine transmembrane transport (GO:1902603) | 2.99550158 |
| 114 | carnitine transport (GO:0015879) | 2.98606699 |
| 115 | amino-acid betaine transport (GO:0015838) | 2.98606699 |
| 116 | fatty acid catabolic process (GO:0009062) | 2.98551995 |
| 117 | cerebellar granule cell differentiation (GO:0021707) | 2.98475589 |
| 118 | positive regulation of fatty acid oxidation (GO:0046321) | 2.98265123 |
| 119 | coenzyme catabolic process (GO:0009109) | 2.97243625 |
| 120 | phospholipid homeostasis (GO:0055091) | 2.96326239 |
| 121 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.95876376 |
| 122 | monocarboxylic acid catabolic process (GO:0072329) | 2.93456272 |
| 123 | regulation of DNA endoreduplication (GO:0032875) | 2.92620317 |
| 124 | positive regulation of histone methylation (GO:0031062) | 2.92355365 |
| 125 | NLS-bearing protein import into nucleus (GO:0006607) | 2.90752155 |
| 126 | bile acid and bile salt transport (GO:0015721) | 2.90347940 |
| 127 | carboxylic acid catabolic process (GO:0046395) | 2.89711174 |
| 128 | organic acid catabolic process (GO:0016054) | 2.89711174 |
| 129 | intestinal cholesterol absorption (GO:0030299) | 2.89508054 |
| 130 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.88251280 |
| 131 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.87892377 |
| 132 | serine family amino acid metabolic process (GO:0009069) | 2.86895861 |
| 133 | histone demethylation (GO:0016577) | 2.86739816 |
| 134 | histone H3-K4 trimethylation (GO:0080182) | 2.86706215 |
| 135 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.86608586 |
| 136 | phospholipid efflux (GO:0033700) | 2.86021610 |
| 137 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.84377458 |
| 138 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.84346778 |
| 139 | positive regulation of glycolytic process (GO:0045821) | 2.82748049 |
| 140 | valine metabolic process (GO:0006573) | 2.82614135 |
| 141 | cholesterol efflux (GO:0033344) | 2.82552449 |
| 142 | L-amino acid import (GO:0043092) | 2.82245564 |
| 143 | glycine metabolic process (GO:0006544) | 2.81746278 |
| 144 | carnitine metabolic process (GO:0009437) | 2.80927669 |
| 145 | presynaptic membrane assembly (GO:0097105) | 2.80190184 |
| 146 | drug transmembrane transport (GO:0006855) | 2.79973596 |
| 147 | acylglycerol catabolic process (GO:0046464) | 2.77587786 |
| 148 | neutral lipid catabolic process (GO:0046461) | 2.77587786 |
| 149 | positive regulation of microtubule polymerization (GO:0031116) | 2.77509166 |
| 150 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.76807714 |
| 151 | regulation of RNA stability (GO:0043487) | 2.76762967 |
| 152 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.76161710 |
| 153 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.76161710 |
| 154 | exogenous drug catabolic process (GO:0042738) | 2.75964944 |
| 155 | tricarboxylic acid metabolic process (GO:0072350) | 2.75439059 |
| 156 | plasma lipoprotein particle assembly (GO:0034377) | 2.75085715 |
| 157 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.71414310 |
| 158 | protein K11-linked deubiquitination (GO:0035871) | 2.71249683 |
| 159 | protein K63-linked deubiquitination (GO:0070536) | 2.70585060 |
| 160 | chromosome organization involved in meiosis (GO:0070192) | 2.68888326 |
| 161 | cell communication by electrical coupling (GO:0010644) | 2.68617524 |
| 162 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.67380180 |
| 163 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.67153995 |
| 164 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.62526263 |
| 165 | histone H4-K16 acetylation (GO:0043984) | 2.60971519 |
| 166 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.60790175 |
| 167 | regulation of neuron projection regeneration (GO:0070570) | 2.58893774 |
| 168 | regulation of axon regeneration (GO:0048679) | 2.58893774 |
| 169 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.58241227 |
| 170 | regulation of centriole replication (GO:0046599) | 2.57775793 |
| 171 | regulation of cell fate specification (GO:0042659) | 2.55866390 |
| 172 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.55772321 |
| 173 | regulation of protein polyubiquitination (GO:1902914) | 2.52992087 |
| 174 | presynaptic membrane organization (GO:0097090) | 2.52856731 |
| 175 | IMP metabolic process (GO:0046040) | 2.52595987 |
| 176 | negative regulation of histone modification (GO:0031057) | 2.52303906 |
| 177 | negative regulation of neurotransmitter transport (GO:0051589) | 2.52097343 |
| 178 | righting reflex (GO:0060013) | 2.52016297 |
| 179 | acrosome assembly (GO:0001675) | 2.51624750 |
| 180 | anterior/posterior axis specification, embryo (GO:0008595) | 2.50996126 |
| 181 | chromatin silencing (GO:0006342) | 2.50167563 |
| 182 | establishment of integrated proviral latency (GO:0075713) | 2.49596345 |
| 183 | regulation of histone methylation (GO:0031060) | 2.49389296 |
| 184 | mitotic G2/M transition checkpoint (GO:0044818) | 2.46987464 |
| 185 | synaptonemal complex organization (GO:0070193) | 2.45301888 |
| 186 | positive regulation of response to oxidative stress (GO:1902884) | 2.42702092 |
| 187 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.42702092 |
| 188 | negative regulation of chromatin modification (GO:1903309) | 2.42065658 |
| 189 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.41559509 |
| 190 | regulation of RNA export from nucleus (GO:0046831) | 2.41542946 |
| 191 | male meiosis I (GO:0007141) | 2.41542755 |
| 192 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.41127189 |
| 193 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.41127189 |
| 194 | actin-myosin filament sliding (GO:0033275) | 2.40578043 |
| 195 | muscle filament sliding (GO:0030049) | 2.40578043 |
| 196 | histone H3-K4 methylation (GO:0051568) | 2.38212356 |
| 197 | protein dealkylation (GO:0008214) | 2.38034215 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.05295095 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.33868973 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.56935643 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.50463347 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.47472141 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.35831492 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.19822786 |
| 8 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.02454773 |
| 9 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.02454773 |
| 10 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.02454773 |
| 11 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.96474581 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.75197358 |
| 13 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.51295627 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.42074734 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.41666673 |
| 16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.28693693 |
| 17 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.26734218 |
| 18 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.25424324 |
| 19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.24218364 |
| 20 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.14800373 |
| 21 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.13583678 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11713596 |
| 23 | FUS_26573619_Chip-Seq_HEK293_Human | 2.02141383 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.93590621 |
| 25 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.89888664 |
| 26 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.85058115 |
| 27 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.83483816 |
| 28 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.79540750 |
| 29 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.79540750 |
| 30 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.75841392 |
| 31 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.73930315 |
| 32 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.73462327 |
| 33 | P300_19829295_ChIP-Seq_ESCs_Human | 1.68744216 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.67314069 |
| 35 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.56563646 |
| 36 | EWS_26573619_Chip-Seq_HEK293_Human | 1.53672222 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.52957183 |
| 38 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.52528238 |
| 39 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.49886415 |
| 40 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.48727975 |
| 41 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.48686187 |
| 42 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.45818025 |
| 43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.44219174 |
| 44 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.42357747 |
| 45 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.40875061 |
| 46 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.40812635 |
| 47 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.40795210 |
| 48 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.40757003 |
| 49 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.39068950 |
| 50 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.38215470 |
| 51 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.37782749 |
| 52 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37590332 |
| 53 | * MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.36581157 |
| 54 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.34113901 |
| 55 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.33404810 |
| 56 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.32807745 |
| 57 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.32412099 |
| 58 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.32101309 |
| 59 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.30906040 |
| 60 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.29534837 |
| 61 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.29491923 |
| 62 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29445863 |
| 63 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26392666 |
| 64 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.23608184 |
| 65 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.22861601 |
| 66 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.22715280 |
| 67 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.22714520 |
| 68 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22203752 |
| 69 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21721542 |
| 70 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.21253938 |
| 71 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.20065692 |
| 72 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.19700662 |
| 73 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 1.19368045 |
| 74 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.19274438 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18867922 |
| 76 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.18011717 |
| 77 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.18002538 |
| 78 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.17841548 |
| 79 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.17841548 |
| 80 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.17479846 |
| 81 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.16550879 |
| 82 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.16517795 |
| 83 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.14184473 |
| 84 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.13587742 |
| 85 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.13361626 |
| 86 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.13205386 |
| 87 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.13198104 |
| 88 | KDM2B_26808549_Chip-Seq_K562_Human | 1.11169071 |
| 89 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.09986395 |
| 90 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.09964209 |
| 91 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.09144053 |
| 92 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08502418 |
| 93 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.08354067 |
| 94 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.08254217 |
| 95 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07216511 |
| 96 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.06418194 |
| 97 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.06278935 |
| 98 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.06278935 |
| 99 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.05395796 |
| 100 | * GF1_26923725_Chip-Seq_HPCs_Mouse | 1.05232620 |
| 101 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.05067977 |
| 102 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.04849252 |
| 103 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.04383747 |
| 104 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.04150068 |
| 105 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.03971280 |
| 106 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03144732 |
| 107 | GATA1_22025678_ChIP-Seq_K562_Human | 1.02825123 |
| 108 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.02280881 |
| 109 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02276698 |
| 110 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.02247863 |
| 111 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01138526 |
| 112 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.00470486 |
| 113 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.00352595 |
| 114 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00330972 |
| 115 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.00158688 |
| 116 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.00142550 |
| 117 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.99901248 |
| 118 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.99403275 |
| 119 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.98459982 |
| 120 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.98066115 |
| 121 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.97979101 |
| 122 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97777374 |
| 123 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.96786725 |
| 124 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.96634650 |
| 125 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96356656 |
| 126 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.95403673 |
| 127 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.94972250 |
| 128 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93160583 |
| 129 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.92713819 |
| 130 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.92392025 |
| 131 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.92068601 |
| 132 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.91898439 |
| 133 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.91125540 |
| 134 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.89805426 |
| 135 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.89761312 |
| 136 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.88691514 |
| 137 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88358409 |
| 138 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.86845358 |
| 139 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86802820 |
| 140 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.86688385 |
| 141 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.86283344 |
| 142 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.86077232 |
| 143 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.83811841 |
| 144 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.83113779 |
| 145 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.82944611 |
| 146 | * AR_19668381_ChIP-Seq_PC3_Human | 0.82595846 |
| 147 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.82517491 |
| 148 | STAT3_23295773_ChIP-Seq_U87_Human | 0.80946311 |
| 149 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.80775172 |
| 150 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.80355223 |
| 151 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80288648 |
| 152 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.80160880 |
| 153 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.79528646 |
| 154 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79219697 |
| 155 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.78552875 |
| 156 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.78284866 |
| 157 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.77971580 |
| 158 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.77534677 |
| 159 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77102527 |
| 160 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.76706695 |
| 161 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.76626889 |
| 162 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.76414981 |
| 163 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.75138269 |
| 164 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.74646177 |
| 165 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.74354263 |
| 166 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.74070060 |
| 167 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.74012016 |
| 168 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.73567113 |
| 169 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.72637134 |
| 170 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.72150193 |
| 171 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.71897285 |
| 172 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.71472968 |
| 173 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.70865273 |
| 174 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.70503912 |
| 175 | * RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.70298579 |
| 176 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69181406 |
| 177 | TP53_16413492_ChIP-PET_HCT116_Human | 0.68168298 |
| 178 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.68134073 |
| 179 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.68124485 |
| 180 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.68019027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.04090900 |
| 2 | MP0005360_urolithiasis | 5.53754809 |
| 3 | MP0008877_abnormal_DNA_methylation | 5.03239635 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.91550593 |
| 5 | MP0005365_abnormal_bile_salt | 4.74335727 |
| 6 | MP0008057_abnormal_DNA_replication | 4.19485884 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.47217535 |
| 8 | MP0003252_abnormal_bile_duct | 3.22289878 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.01976383 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.74466791 |
| 11 | MP0003890_abnormal_embryonic-extraembry | 2.72494388 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 2.72009397 |
| 13 | MP0002254_reproductive_system_inflammat | 2.48372213 |
| 14 | MP0003787_abnormal_imprinting | 2.47939972 |
| 15 | MP0005083_abnormal_biliary_tract | 2.30949444 |
| 16 | MP0004130_abnormal_muscle_cell | 2.20630038 |
| 17 | MP0000569_abnormal_digit_pigmentation | 2.15767643 |
| 18 | MP0003195_calcinosis | 2.13998972 |
| 19 | MP0005332_abnormal_amino_acid | 2.11351278 |
| 20 | MP0002009_preneoplasia | 2.09301693 |
| 21 | MP0009840_abnormal_foam_cell | 2.05857183 |
| 22 | MP0001666_abnormal_nutrient_absorption | 2.04894062 |
| 23 | MP0003705_abnormal_hypodermis_morpholog | 2.02331382 |
| 24 | MP0003941_abnormal_skin_development | 1.99518223 |
| 25 | MP0010234_abnormal_vibrissa_follicle | 1.97638638 |
| 26 | MP0001188_hyperpigmentation | 1.90120773 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 1.86431087 |
| 28 | MP0003646_muscle_fatigue | 1.82637406 |
| 29 | MP0004043_abnormal_pH_regulation | 1.82348303 |
| 30 | MP0009703_decreased_birth_body | 1.80716782 |
| 31 | MP0003868_abnormal_feces_composition | 1.73478738 |
| 32 | MP0003567_abnormal_fetal_cardiomyocyte | 1.72378393 |
| 33 | MP0004145_abnormal_muscle_electrophysio | 1.71030880 |
| 34 | MP0000609_abnormal_liver_physiology | 1.69360023 |
| 35 | MP0004185_abnormal_adipocyte_glucose | 1.67239702 |
| 36 | MP0004957_abnormal_blastocyst_morpholog | 1.65948100 |
| 37 | MP0002272_abnormal_nervous_system | 1.64970324 |
| 38 | MP0004742_abnormal_vestibular_system | 1.63470429 |
| 39 | MP0002909_abnormal_adrenal_gland | 1.62897901 |
| 40 | MP0005076_abnormal_cell_differentiation | 1.61192337 |
| 41 | MP0000751_myopathy | 1.58965391 |
| 42 | MP0005666_abnormal_adipose_tissue | 1.53895604 |
| 43 | MP0010307_abnormal_tumor_latency | 1.51893956 |
| 44 | MP0001486_abnormal_startle_reflex | 1.51726411 |
| 45 | MP0002269_muscular_atrophy | 1.49791042 |
| 46 | MP0004484_altered_response_of | 1.46182961 |
| 47 | MP0004036_abnormal_muscle_relaxation | 1.46001843 |
| 48 | MP0003693_abnormal_embryo_hatching | 1.44778043 |
| 49 | MP0009745_abnormal_behavioral_response | 1.42691400 |
| 50 | MP0002971_abnormal_brown_adipose | 1.41886962 |
| 51 | MP0003121_genomic_imprinting | 1.40230061 |
| 52 | MP0004019_abnormal_vitamin_homeostasis | 1.37839218 |
| 53 | MP0002078_abnormal_glucose_homeostasis | 1.36897949 |
| 54 | MP0000747_muscle_weakness | 1.36892105 |
| 55 | MP0001730_embryonic_growth_arrest | 1.35757804 |
| 56 | MP0008961_abnormal_basal_metabolism | 1.35039993 |
| 57 | MP0001177_atelectasis | 1.34561551 |
| 58 | MP0004270_analgesia | 1.32118178 |
| 59 | MP0005187_abnormal_penis_morphology | 1.30024569 |
| 60 | MP0009780_abnormal_chondrocyte_physiolo | 1.29883796 |
| 61 | MP0008569_lethality_at_weaning | 1.28524508 |
| 62 | MP0004087_abnormal_muscle_fiber | 1.28146992 |
| 63 | MP0004215_abnormal_myocardial_fiber | 1.27999620 |
| 64 | MP0001440_abnormal_grooming_behavior | 1.27118694 |
| 65 | MP0002063_abnormal_learning/memory/cond | 1.25394253 |
| 66 | MP0003329_amyloid_beta_deposits | 1.25316671 |
| 67 | MP0005319_abnormal_enzyme/_coenzyme | 1.22949807 |
| 68 | MP0002064_seizures | 1.21938030 |
| 69 | MP0004084_abnormal_cardiac_muscle | 1.18122254 |
| 70 | MP0003191_abnormal_cellular_cholesterol | 1.15952993 |
| 71 | MP0005330_cardiomyopathy | 1.15249955 |
| 72 | MP0006036_abnormal_mitochondrial_physio | 1.13912784 |
| 73 | MP0005535_abnormal_body_temperature | 1.13670184 |
| 74 | MP0003123_paternal_imprinting | 1.12860737 |
| 75 | MP0001501_abnormal_sleep_pattern | 1.12655509 |
| 76 | MP0004859_abnormal_synaptic_plasticity | 1.12449632 |
| 77 | MP0004233_abnormal_muscle_weight | 1.12237477 |
| 78 | MP0005375_adipose_tissue_phenotype | 1.11479322 |
| 79 | MP0002067_abnormal_sensory_capabilities | 1.11280845 |
| 80 | MP0002138_abnormal_hepatobiliary_system | 1.10896029 |
| 81 | MP0002877_abnormal_melanocyte_morpholog | 1.10534163 |
| 82 | MP0005451_abnormal_body_composition | 1.10442752 |
| 83 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.10044173 |
| 84 | MP0010352_gastrointestinal_tract_polyps | 1.08644984 |
| 85 | MP0003718_maternal_effect | 1.08458873 |
| 86 | MP0002736_abnormal_nociception_after | 1.07005094 |
| 87 | MP0003119_abnormal_digestive_system | 1.03987117 |
| 88 | MP0008058_abnormal_DNA_repair | 1.03924638 |
| 89 | MP0003111_abnormal_nucleus_morphology | 1.03735147 |
| 90 | MP0002210_abnormal_sex_determination | 1.03686147 |
| 91 | MP0004264_abnormal_extraembryonic_tissu | 1.03369798 |
| 92 | MP0004197_abnormal_fetal_growth/weight/ | 1.03265678 |
| 93 | MP0003122_maternal_imprinting | 1.00762137 |
| 94 | MP0002084_abnormal_developmental_patter | 0.96722246 |
| 95 | MP0000013_abnormal_adipose_tissue | 0.95348502 |
| 96 | MP0005380_embryogenesis_phenotype | 0.93206388 |
| 97 | MP0001672_abnormal_embryogenesis/_devel | 0.93206388 |
| 98 | MP0003698_abnormal_male_reproductive | 0.92927080 |
| 99 | MP0005423_abnormal_somatic_nervous | 0.92859907 |
| 100 | MP0002088_abnormal_embryonic_growth/wei | 0.92086238 |
| 101 | MP0004811_abnormal_neuron_physiology | 0.91886114 |
| 102 | MP0003984_embryonic_growth_retardation | 0.91680899 |
| 103 | MP0000749_muscle_degeneration | 0.91537382 |
| 104 | MP0005620_abnormal_muscle_contractility | 0.91178060 |
| 105 | MP0009643_abnormal_urine_homeostasis | 0.91043053 |
| 106 | MP0001944_abnormal_pancreas_morphology | 0.90635727 |
| 107 | MP0005334_abnormal_fat_pad | 0.90085341 |
| 108 | MP0000003_abnormal_adipose_tissue | 0.89831270 |
| 109 | MP0005266_abnormal_metabolism | 0.88043006 |
| 110 | MP0000428_abnormal_craniofacial_morphol | 0.86655230 |
| 111 | MP0001929_abnormal_gametogenesis | 0.86473152 |
| 112 | MP0001145_abnormal_male_reproductive | 0.85547840 |
| 113 | MP0000350_abnormal_cell_proliferation | 0.84933270 |
| 114 | MP0001485_abnormal_pinna_reflex | 0.83877900 |
| 115 | MP0003300_gastrointestinal_ulcer | 0.83297202 |
| 116 | MP0002734_abnormal_mechanical_nocicepti | 0.83080012 |
| 117 | MP0010094_abnormal_chromosome_stability | 0.82961290 |
| 118 | MP0002106_abnormal_muscle_physiology | 0.82532954 |
| 119 | MP0002822_catalepsy | 0.82246104 |
| 120 | MP0004885_abnormal_endolymph | 0.82094760 |
| 121 | MP0001697_abnormal_embryo_size | 0.81740679 |
| 122 | MP0005670_abnormal_white_adipose | 0.80958373 |
| 123 | MP0000604_amyloidosis | 0.80720221 |
| 124 | MP0001984_abnormal_olfaction | 0.79812964 |
| 125 | MP0010630_abnormal_cardiac_muscle | 0.79288291 |
| 126 | MP0006072_abnormal_retinal_apoptosis | 0.78818335 |
| 127 | MP0003283_abnormal_digestive_organ | 0.78777177 |
| 128 | MP0000759_abnormal_skeletal_muscle | 0.78354495 |
| 129 | MP0002152_abnormal_brain_morphology | 0.77642980 |
| 130 | MP0003136_yellow_coat_color | 0.77425382 |
| 131 | MP0000653_abnormal_sex_gland | 0.77123639 |
| 132 | MP0005551_abnormal_eye_electrophysiolog | 0.77067013 |
| 133 | MP0003635_abnormal_synaptic_transmissio | 0.76549806 |
| 134 | MP0003861_abnormal_nervous_system | 0.76449390 |
| 135 | MP0000778_abnormal_nervous_system | 0.76299141 |
| 136 | MP0003656_abnormal_erythrocyte_physiolo | 0.76284063 |
| 137 | MP0003077_abnormal_cell_cycle | 0.76040821 |
| 138 | MP0009046_muscle_twitch | 0.75930912 |
| 139 | MP0003880_abnormal_central_pattern | 0.74834492 |
| 140 | MP0002693_abnormal_pancreas_physiology | 0.73239382 |
| 141 | MP0001299_abnormal_eye_distance/ | 0.73162284 |
| 142 | MP0009672_abnormal_birth_weight | 0.72765505 |
| 143 | MP0000631_abnormal_neuroendocrine_gland | 0.72671494 |
| 144 | MP0003699_abnormal_female_reproductive | 0.71889441 |
| 145 | * MP0002085_abnormal_embryonic_tissue | 0.71567636 |
| 146 | MP0002086_abnormal_extraembryonic_tissu | 0.71172888 |
| 147 | MP0003137_abnormal_impulse_conducting | 0.70563298 |
| 148 | MP0001765_abnormal_ion_homeostasis | 0.70381289 |
| 149 | MP0003221_abnormal_cardiomyocyte_apopto | 0.69860782 |
| 150 | MP0002066_abnormal_motor_capabilities/c | 0.69755314 |
| 151 | MP0004085_abnormal_heartbeat | 0.69177338 |
| 152 | MP0008775_abnormal_heart_ventricle | 0.68886208 |
| 153 | MP0005448_abnormal_energy_balance | 0.68562447 |
| 154 | MP0002796_impaired_skin_barrier | 0.67762662 |
| 155 | MP0001764_abnormal_homeostasis | 0.66970064 |
| 156 | MP0003953_abnormal_hormone_level | 0.66593102 |
| 157 | MP0003633_abnormal_nervous_system | 0.66092460 |
| 158 | MP0003690_abnormal_glial_cell | 0.64790437 |
| 159 | MP0000598_abnormal_liver_morphology | 0.64705468 |
| 160 | MP0002332_abnormal_exercise_endurance | 0.64013157 |
| 161 | MP0003045_fibrosis | 0.63819019 |
| 162 | MP0000639_abnormal_adrenal_gland | 0.63416245 |
| 163 | MP0005369_muscle_phenotype | 0.62865062 |
| 164 | MP0002972_abnormal_cardiac_muscle | 0.61469002 |
| 165 | MP0006035_abnormal_mitochondrial_morpho | 0.60565840 |
| 166 | MP0008874_decreased_physiological_sensi | 0.60022899 |
| 167 | MP0001661_extended_life_span | 0.59589728 |
| 168 | MP0002229_neurodegeneration | 0.59274123 |
| 169 | MP0005636_abnormal_mineral_homeostasis | 0.59193165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 5.04667925 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.85208458 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.67632540 |
| 4 | Hypoglycemic coma (HP:0001325) | 4.37520489 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.29360744 |
| 6 | Xanthomatosis (HP:0000991) | 4.28691940 |
| 7 | Nemaline bodies (HP:0003798) | 4.13596938 |
| 8 | Ketosis (HP:0001946) | 4.10776266 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 4.07650603 |
| 10 | Ketoacidosis (HP:0001993) | 3.95968735 |
| 11 | Rimmed vacuoles (HP:0003805) | 3.93808341 |
| 12 | Hepatoblastoma (HP:0002884) | 3.74470047 |
| 13 | Exercise-induced myalgia (HP:0003738) | 3.58882539 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 3.57692647 |
| 15 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.56358932 |
| 16 | Hypolipoproteinemia (HP:0010981) | 3.47946400 |
| 17 | Hyperammonemia (HP:0001987) | 3.46119527 |
| 18 | Hyperglycinemia (HP:0002154) | 3.39556496 |
| 19 | Hyperglycinuria (HP:0003108) | 3.39147280 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 3.38290042 |
| 21 | Septo-optic dysplasia (HP:0100842) | 3.37299797 |
| 22 | Epidermoid cyst (HP:0200040) | 3.30919093 |
| 23 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.29286371 |
| 24 | Subaortic stenosis (HP:0001682) | 3.29286371 |
| 25 | Biliary tract neoplasm (HP:0100574) | 3.24782527 |
| 26 | Myoglobinuria (HP:0002913) | 3.24780038 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.21193016 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.21193016 |
| 29 | Prolonged partial thromboplastin time (HP:0003645) | 3.19346467 |
| 30 | Febrile seizures (HP:0002373) | 3.14024136 |
| 31 | Atonic seizures (HP:0010819) | 3.13061865 |
| 32 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.11243690 |
| 33 | Hyperglycemia (HP:0003074) | 3.10050368 |
| 34 | Complement deficiency (HP:0004431) | 3.07958557 |
| 35 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.06347053 |
| 36 | Hypoglycemic seizures (HP:0002173) | 3.03608587 |
| 37 | Muscle fiber splitting (HP:0003555) | 2.98518292 |
| 38 | Abnormality of the common coagulation pathway (HP:0010990) | 2.85758109 |
| 39 | Gout (HP:0001997) | 2.85270806 |
| 40 | Skin nodule (HP:0200036) | 2.82664417 |
| 41 | Hyporeflexia of lower limbs (HP:0002600) | 2.81952030 |
| 42 | Abnormality of the labia minora (HP:0012880) | 2.78187748 |
| 43 | Abnormality of the septum pellucidum (HP:0007375) | 2.76847829 |
| 44 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.76698316 |
| 45 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.76686386 |
| 46 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.75972096 |
| 47 | Exercise-induced muscle cramps (HP:0003710) | 2.73618131 |
| 48 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.71789020 |
| 49 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.71789020 |
| 50 | Papillary thyroid carcinoma (HP:0002895) | 2.71774185 |
| 51 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.68063618 |
| 52 | Action tremor (HP:0002345) | 2.61642128 |
| 53 | Volvulus (HP:0002580) | 2.57928152 |
| 54 | Embryonal renal neoplasm (HP:0011794) | 2.57276359 |
| 55 | Gaze-evoked nystagmus (HP:0000640) | 2.57273033 |
| 56 | Hypochromic microcytic anemia (HP:0004840) | 2.56368598 |
| 57 | Conjugated hyperbilirubinemia (HP:0002908) | 2.54626795 |
| 58 | Dysmetric saccades (HP:0000641) | 2.52423951 |
| 59 | Shoulder girdle muscle weakness (HP:0003547) | 2.52181163 |
| 60 | Fat malabsorption (HP:0002630) | 2.49621831 |
| 61 | Late onset (HP:0003584) | 2.47723078 |
| 62 | Global brain atrophy (HP:0002283) | 2.46139042 |
| 63 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.44325121 |
| 64 | Gastrointestinal carcinoma (HP:0002672) | 2.43902723 |
| 65 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.43902723 |
| 66 | Pelvic girdle muscle weakness (HP:0003749) | 2.42968521 |
| 67 | Abnormality of the corticospinal tract (HP:0002492) | 2.42734680 |
| 68 | Abnormality of purine metabolism (HP:0004352) | 2.41249846 |
| 69 | Abnormality of the intrinsic pathway (HP:0010989) | 2.39510253 |
| 70 | Genetic anticipation (HP:0003743) | 2.38028898 |
| 71 | Progressive cerebellar ataxia (HP:0002073) | 2.36566260 |
| 72 | Abnormality of the lower motor neuron (HP:0002366) | 2.35723571 |
| 73 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.34827875 |
| 74 | Difficulty running (HP:0009046) | 2.32869838 |
| 75 | Cholelithiasis (HP:0001081) | 2.32712239 |
| 76 | Absence seizures (HP:0002121) | 2.31923017 |
| 77 | Stomach cancer (HP:0012126) | 2.31752022 |
| 78 | Hypercholesterolemia (HP:0003124) | 2.31196302 |
| 79 | Postural instability (HP:0002172) | 2.30155919 |
| 80 | Dialeptic seizures (HP:0011146) | 2.29954845 |
| 81 | Acanthocytosis (HP:0001927) | 2.29569121 |
| 82 | Abnormal gallbladder morphology (HP:0012437) | 2.29392060 |
| 83 | Urinary urgency (HP:0000012) | 2.29334234 |
| 84 | Maternal diabetes (HP:0009800) | 2.29001250 |
| 85 | Sudden death (HP:0001699) | 2.28736730 |
| 86 | Protruding tongue (HP:0010808) | 2.28118678 |
| 87 | Neoplasm of the small intestine (HP:0100833) | 2.27521862 |
| 88 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.25530515 |
| 89 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.25530515 |
| 90 | Status epilepticus (HP:0002133) | 2.23480770 |
| 91 | Hyperbilirubinemia (HP:0002904) | 2.23440535 |
| 92 | Abnormality of methionine metabolism (HP:0010901) | 2.23314228 |
| 93 | Absent septum pellucidum (HP:0001331) | 2.22957267 |
| 94 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.19865087 |
| 95 | Chronic bronchitis (HP:0004469) | 2.19530277 |
| 96 | Gonadotropin excess (HP:0000837) | 2.18664160 |
| 97 | Metabolic acidosis (HP:0001942) | 2.18616840 |
| 98 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.18090966 |
| 99 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.18090966 |
| 100 | Broad-based gait (HP:0002136) | 2.17544923 |
| 101 | Bundle branch block (HP:0011710) | 2.16134874 |
| 102 | Back pain (HP:0003418) | 2.16011908 |
| 103 | Focal motor seizures (HP:0011153) | 2.15171720 |
| 104 | Impaired vibratory sensation (HP:0002495) | 2.15165961 |
| 105 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.12874062 |
| 106 | Cholecystitis (HP:0001082) | 2.12049497 |
| 107 | Abnormal gallbladder physiology (HP:0012438) | 2.12049497 |
| 108 | EMG: myopathic abnormalities (HP:0003458) | 2.10988807 |
| 109 | Abnormality of the Achilles tendon (HP:0005109) | 2.10651751 |
| 110 | 2-3 toe syndactyly (HP:0004691) | 2.09586999 |
| 111 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.08583880 |
| 112 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.08042790 |
| 113 | EMG: neuropathic changes (HP:0003445) | 2.07171659 |
| 114 | Abnormality of nucleobase metabolism (HP:0010932) | 2.06184925 |
| 115 | Aplasia involving bones of the extremities (HP:0009825) | 2.04478170 |
| 116 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.04478170 |
| 117 | Aplasia of the phalanges of the hand (HP:0009802) | 2.04478170 |
| 118 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.04089590 |
| 119 | Symptomatic seizures (HP:0011145) | 2.03637218 |
| 120 | Inappropriate behavior (HP:0000719) | 2.02830191 |
| 121 | Spastic diplegia (HP:0001264) | 2.02774433 |
| 122 | Leiomyosarcoma (HP:0100243) | 2.02072254 |
| 123 | Uterine leiomyosarcoma (HP:0002891) | 2.02072254 |
| 124 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.00482914 |
| 125 | Muscle fiber inclusion bodies (HP:0100299) | 2.00070456 |
| 126 | Calf muscle hypertrophy (HP:0008981) | 2.00028803 |
| 127 | Abnormality of serum amino acid levels (HP:0003112) | 1.99220045 |
| 128 | Aqueductal stenosis (HP:0002410) | 1.98949340 |
| 129 | Focal seizures (HP:0007359) | 1.98107812 |
| 130 | Abnormality of complement system (HP:0005339) | 1.97866508 |
| 131 | T lymphocytopenia (HP:0005403) | 1.97806052 |
| 132 | Type 1 muscle fiber predominance (HP:0003803) | 1.97785869 |
| 133 | Increased purine levels (HP:0004368) | 1.97301207 |
| 134 | Hyperuricemia (HP:0002149) | 1.97301207 |
| 135 | Rhabdomyolysis (HP:0003201) | 1.96633370 |
| 136 | Supernumerary spleens (HP:0009799) | 1.95814612 |
| 137 | Neonatal hypoglycemia (HP:0001998) | 1.95769455 |
| 138 | Germ cell neoplasia (HP:0100728) | 1.94691871 |
| 139 | Abnormal biliary tract morphology (HP:0012440) | 1.93130172 |
| 140 | Turricephaly (HP:0000262) | 1.92795166 |
| 141 | Atrioventricular block (HP:0001678) | 1.92132304 |
| 142 | Generalized tonic-clonic seizures (HP:0002069) | 1.91982434 |
| 143 | Depressed nasal tip (HP:0000437) | 1.91639339 |
| 144 | Disinhibition (HP:0000734) | 1.91048108 |
| 145 | Slow saccadic eye movements (HP:0000514) | 1.90039780 |
| 146 | Scanning speech (HP:0002168) | 1.90017214 |
| 147 | Bladder neoplasm (HP:0009725) | 1.89752633 |
| 148 | Bladder carcinoma (HP:0002862) | 1.89752633 |
| 149 | Right ventricular cardiomyopathy (HP:0011663) | 1.88845864 |
| 150 | Resting tremor (HP:0002322) | 1.88038602 |
| 151 | Hepatocellular carcinoma (HP:0001402) | 1.87872854 |
| 152 | Dicarboxylic aciduria (HP:0003215) | 1.87737752 |
| 153 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.87737752 |
| 154 | Delayed CNS myelination (HP:0002188) | 1.87476102 |
| 155 | Irritability (HP:0000737) | 1.86066753 |
| 156 | Sensorimotor neuropathy (HP:0007141) | 1.85816271 |
| 157 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.85584576 |
| 158 | Areflexia of lower limbs (HP:0002522) | 1.84472249 |
| 159 | Asymmetric septal hypertrophy (HP:0001670) | 1.84169780 |
| 160 | Thickened helices (HP:0000391) | 1.84014226 |
| 161 | Neonatal onset (HP:0003623) | 1.83781833 |
| 162 | Megalencephaly (HP:0001355) | 1.83041400 |
| 163 | Optic nerve hypoplasia (HP:0000609) | 1.82722570 |
| 164 | Malnutrition (HP:0004395) | 1.82554157 |
| 165 | Colon cancer (HP:0003003) | 1.81210369 |
| 166 | Reticulocytosis (HP:0001923) | 1.80287603 |
| 167 | Acute myeloid leukemia (HP:0004808) | 1.80182040 |
| 168 | Dysdiadochokinesis (HP:0002075) | 1.80011759 |
| 169 | Poikilocytosis (HP:0004447) | 1.79815305 |
| 170 | Embryonal neoplasm (HP:0002898) | 1.79306495 |
| 171 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.78354041 |
| 172 | Myocardial infarction (HP:0001658) | 1.78148495 |
| 173 | Truncal obesity (HP:0001956) | 1.77543425 |
| 174 | Polycythemia (HP:0001901) | 1.77212677 |
| 175 | Abnormality of the salivary glands (HP:0010286) | 1.76296981 |
| 176 | Joint hemorrhage (HP:0005261) | 1.76017556 |
| 177 | Hyperkalemia (HP:0002153) | 1.75941549 |
| 178 | Acute hepatic failure (HP:0006554) | 1.75298030 |
| 179 | Uterine neoplasm (HP:0010784) | 1.74389475 |
| 180 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.74102098 |
| 181 | Muscle stiffness (HP:0003552) | 1.73061991 |
| 182 | Heart block (HP:0012722) | 1.72667343 |
| 183 | Insulin resistance (HP:0000855) | 1.72412140 |
| 184 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.71716920 |
| 185 | Abnormality of saccadic eye movements (HP:0000570) | 1.70191864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 3.28957697 |
| 2 | STK24 | 2.96411075 |
| 3 | MKNK2 | 2.78938143 |
| 4 | CDK19 | 2.78896308 |
| 5 | TRIB3 | 2.75243313 |
| 6 | LATS1 | 2.59754504 |
| 7 | MAP3K9 | 2.37344376 |
| 8 | PDK4 | 2.36699928 |
| 9 | PDK3 | 2.36699928 |
| 10 | MAP2K4 | 2.32332777 |
| 11 | INSRR | 2.31828854 |
| 12 | BRD4 | 2.22752649 |
| 13 | BCKDK | 2.13175306 |
| 14 | PKN2 | 2.12669434 |
| 15 | KSR2 | 2.11581746 |
| 16 | MKNK1 | 2.07037510 |
| 17 | CDC7 | 2.04096093 |
| 18 | TAOK3 | 1.95986714 |
| 19 | PINK1 | 1.92307931 |
| 20 | OBSCN | 1.80148136 |
| 21 | CASK | 1.77783785 |
| 22 | MAP3K2 | 1.73909362 |
| 23 | NLK | 1.73531385 |
| 24 | MAP3K4 | 1.72113605 |
| 25 | ICK | 1.71850797 |
| 26 | PRKD3 | 1.67029241 |
| 27 | TTK | 1.66845888 |
| 28 | MAP3K6 | 1.66574053 |
| 29 | NEK1 | 1.62487889 |
| 30 | NTRK3 | 1.55771395 |
| 31 | YES1 | 1.55507585 |
| 32 | SIK1 | 1.54376520 |
| 33 | STK38 | 1.52252551 |
| 34 | RET | 1.51961153 |
| 35 | TTN | 1.49519509 |
| 36 | RIPK1 | 1.47238649 |
| 37 | LATS2 | 1.40844893 |
| 38 | FGFR4 | 1.39545536 |
| 39 | TYRO3 | 1.39515149 |
| 40 | PAK6 | 1.37533216 |
| 41 | RPS6KA4 | 1.37266272 |
| 42 | OXSR1 | 1.32648210 |
| 43 | PHKG1 | 1.31313575 |
| 44 | PHKG2 | 1.31313575 |
| 45 | PDGFRA | 1.29380442 |
| 46 | BLK | 1.24172871 |
| 47 | CAMK1G | 1.23956978 |
| 48 | DYRK3 | 1.21920212 |
| 49 | MAP3K7 | 1.19757383 |
| 50 | ERBB4 | 1.15942986 |
| 51 | UHMK1 | 1.12698702 |
| 52 | PRKAA1 | 1.12301338 |
| 53 | TAOK1 | 1.09939856 |
| 54 | CDK12 | 1.09650546 |
| 55 | CAMK1D | 1.09288963 |
| 56 | DAPK2 | 1.07303793 |
| 57 | PTK6 | 1.06717161 |
| 58 | FRK | 1.04590828 |
| 59 | EPHA4 | 1.02098188 |
| 60 | PASK | 1.01482504 |
| 61 | WNK4 | 1.00637690 |
| 62 | LMTK2 | 0.99945346 |
| 63 | MAP3K1 | 0.97377347 |
| 64 | PRKAA2 | 0.97077177 |
| 65 | FGFR2 | 0.96575762 |
| 66 | WNK1 | 0.94126978 |
| 67 | PDK2 | 0.93823868 |
| 68 | SGK3 | 0.93241485 |
| 69 | PNCK | 0.91633855 |
| 70 | DMPK | 0.91308802 |
| 71 | TAF1 | 0.91097029 |
| 72 | PDPK1 | 0.90432944 |
| 73 | PDK1 | 0.88969145 |
| 74 | PLK3 | 0.85363536 |
| 75 | PAK3 | 0.85074833 |
| 76 | JAK2 | 0.84795446 |
| 77 | KSR1 | 0.84319398 |
| 78 | MAPK11 | 0.84116842 |
| 79 | CAMK4 | 0.83635148 |
| 80 | PIM1 | 0.83206254 |
| 81 | STK11 | 0.80935047 |
| 82 | PRPF4B | 0.80274235 |
| 83 | ACVR1B | 0.76327635 |
| 84 | SRPK1 | 0.75768263 |
| 85 | DYRK1A | 0.75471311 |
| 86 | HIPK2 | 0.73639047 |
| 87 | DYRK1B | 0.73131392 |
| 88 | ERN1 | 0.71021890 |
| 89 | PRKCH | 0.70910692 |
| 90 | MAP3K10 | 0.70803139 |
| 91 | MTOR | 0.69739018 |
| 92 | CAMKK1 | 0.69701559 |
| 93 | PLK2 | 0.69668129 |
| 94 | PTK2 | 0.69582337 |
| 95 | MAP3K13 | 0.67462293 |
| 96 | MARK1 | 0.67034732 |
| 97 | FGFR1 | 0.66367268 |
| 98 | MAP3K5 | 0.66328275 |
| 99 | NTRK1 | 0.66285624 |
| 100 | ZAK | 0.66186831 |
| 101 | CDK6 | 0.65641765 |
| 102 | EEF2K | 0.65472159 |
| 103 | CAMK1 | 0.64246701 |
| 104 | PRKD1 | 0.62395743 |
| 105 | STK39 | 0.62275607 |
| 106 | TSSK6 | 0.60992315 |
| 107 | ALK | 0.60724809 |
| 108 | FGR | 0.58089305 |
| 109 | CSNK1E | 0.57585971 |
| 110 | MAPK12 | 0.57042999 |
| 111 | STK3 | 0.55576965 |
| 112 | AKT3 | 0.54620263 |
| 113 | CDK3 | 0.54541026 |
| 114 | SGK2 | 0.54046402 |
| 115 | MAP2K3 | 0.54034286 |
| 116 | MELK | 0.54006100 |
| 117 | RPS6KA3 | 0.53857670 |
| 118 | SGK494 | 0.53570606 |
| 119 | SGK223 | 0.53570606 |
| 120 | PRKG1 | 0.52991889 |
| 121 | RPS6KB1 | 0.52889684 |
| 122 | EGFR | 0.52611220 |
| 123 | PRKACG | 0.52205515 |
| 124 | MET | 0.50877956 |
| 125 | SGK1 | 0.50724787 |
| 126 | SCYL2 | 0.50712401 |
| 127 | FLT3 | 0.49854192 |
| 128 | FER | 0.49691159 |
| 129 | FGFR3 | 0.48558251 |
| 130 | RPS6KB2 | 0.48090287 |
| 131 | PDGFRB | 0.47852949 |
| 132 | CDC42BPA | 0.46809039 |
| 133 | MAPK15 | 0.46709913 |
| 134 | DDR2 | 0.46001108 |
| 135 | CAMK2G | 0.45494534 |
| 136 | NTRK2 | 0.45358430 |
| 137 | PIK3CG | 0.44519055 |
| 138 | EPHB1 | 0.44065507 |
| 139 | STK4 | 0.43093684 |
| 140 | ATM | 0.41857147 |
| 141 | CDK5 | 0.41504760 |
| 142 | STK38L | 0.41414137 |
| 143 | MAPK10 | 0.41079443 |
| 144 | MAPK7 | 0.40862035 |
| 145 | MOS | 0.40714012 |
| 146 | MARK2 | 0.39863652 |
| 147 | CSNK1D | 0.39515223 |
| 148 | GSK3B | 0.38722253 |
| 149 | MARK3 | 0.38659041 |
| 150 | RIPK4 | 0.38471636 |
| 151 | CHEK1 | 0.36695532 |
| 152 | NEK6 | 0.35519976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.57745651 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.45814211 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.17024836 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.01160662 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.39900493 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.37066391 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.34584794 |
| 8 | Long-term depression_Homo sapiens_hsa04730 | 2.30272641 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.24932981 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 2.23284340 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.20090924 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14505195 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.12554719 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.04860664 |
| 15 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.00979779 |
| 16 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.98668254 |
| 17 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.93742462 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.93166822 |
| 19 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.85980239 |
| 20 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.77175185 |
| 21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.74319035 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.71854767 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.69989329 |
| 24 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.68803272 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.67329280 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.52409520 |
| 27 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.52042010 |
| 28 | Adherens junction_Homo sapiens_hsa04520 | 1.49827720 |
| 29 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.44532658 |
| 30 | Endometrial cancer_Homo sapiens_hsa05213 | 1.41818140 |
| 31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.36802139 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.33976016 |
| 33 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.31633362 |
| 34 | Cell cycle_Homo sapiens_hsa04110 | 1.28119975 |
| 35 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.26982578 |
| 36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.25215883 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.24307584 |
| 38 | Tight junction_Homo sapiens_hsa04530 | 1.24097998 |
| 39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23824993 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.22486608 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.22380086 |
| 42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19767831 |
| 43 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.18499897 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.17492239 |
| 45 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.16134202 |
| 46 | Thyroid cancer_Homo sapiens_hsa05216 | 1.15140882 |
| 47 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.14955871 |
| 48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.14664819 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.11859804 |
| 50 | RNA degradation_Homo sapiens_hsa03018 | 1.11060895 |
| 51 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.10968714 |
| 52 | Lysine degradation_Homo sapiens_hsa00310 | 1.10297844 |
| 53 | Prostate cancer_Homo sapiens_hsa05215 | 1.10041484 |
| 54 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.08978838 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.08643391 |
| 56 | Taste transduction_Homo sapiens_hsa04742 | 1.05233403 |
| 57 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.04246811 |
| 58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.01962412 |
| 59 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.00338625 |
| 60 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.00218399 |
| 61 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99925046 |
| 62 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.99362723 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98617906 |
| 64 | Morphine addiction_Homo sapiens_hsa05032 | 0.96077041 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.95886070 |
| 66 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.95852396 |
| 67 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.95232363 |
| 68 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.95198592 |
| 69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.94551664 |
| 70 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92923918 |
| 71 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.91960421 |
| 72 | Colorectal cancer_Homo sapiens_hsa05210 | 0.91664809 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.90255278 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.89551011 |
| 75 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.88398232 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.87438577 |
| 77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86787015 |
| 78 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.86074275 |
| 79 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.85530117 |
| 80 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.85211724 |
| 81 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.85043962 |
| 82 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.84909266 |
| 83 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.84653066 |
| 84 | RNA transport_Homo sapiens_hsa03013 | 0.84089486 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.83289026 |
| 86 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.83288569 |
| 87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.83100943 |
| 88 | Insulin secretion_Homo sapiens_hsa04911 | 0.80853008 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.80825417 |
| 90 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.80368264 |
| 91 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.79072610 |
| 92 | Gap junction_Homo sapiens_hsa04540 | 0.78832888 |
| 93 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.74724911 |
| 94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74463248 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72770941 |
| 96 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.72683523 |
| 97 | Spliceosome_Homo sapiens_hsa03040 | 0.71953251 |
| 98 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.71349140 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.70992914 |
| 100 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.70403455 |
| 101 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.69884723 |
| 102 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69684926 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68965149 |
| 104 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67810219 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67708921 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.66704252 |
| 107 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66684170 |
| 108 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66550071 |
| 109 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66310705 |
| 110 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.64452742 |
| 111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63476355 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63247874 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62300837 |
| 114 | Basal transcription factors_Homo sapiens_hsa03022 | 0.61877385 |
| 115 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59224971 |
| 116 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.58970603 |
| 117 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58184738 |
| 118 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57355194 |
| 119 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57105477 |
| 120 | Long-term potentiation_Homo sapiens_hsa04720 | 0.55747622 |
| 121 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.55573117 |
| 122 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.55006685 |
| 123 | Glioma_Homo sapiens_hsa05214 | 0.54059007 |
| 124 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52986565 |
| 125 | GABAergic synapse_Homo sapiens_hsa04727 | 0.52907871 |
| 126 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.52310264 |
| 127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51263442 |
| 128 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49927550 |
| 129 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.48324617 |
| 130 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47337876 |
| 131 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.44924762 |
| 132 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.44327690 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43133301 |
| 134 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.39182853 |
| 135 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.38953574 |
| 136 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.38416381 |
| 137 | Renin secretion_Homo sapiens_hsa04924 | 0.38285348 |
| 138 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.36092716 |
| 139 | Prion diseases_Homo sapiens_hsa05020 | 0.35541035 |
| 140 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.34999846 |
| 141 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.32625129 |
| 142 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.32297481 |
| 143 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.32240572 |
| 144 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31961735 |
| 145 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.31522130 |
| 146 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.31489886 |
| 147 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.31435260 |
| 148 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.31066543 |
| 149 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29908563 |
| 150 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.29520295 |
| 151 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.28993534 |
| 152 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.28859384 |
| 153 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.28594874 |
| 154 | Salivary secretion_Homo sapiens_hsa04970 | 0.27102796 |
| 155 | Circadian entrainment_Homo sapiens_hsa04713 | 0.26997647 |
| 156 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.26178510 |

